IRCT20210816052203N1尚未招募3 期
Evaluation of the effect of Donepezil Hydrochloride on memory impairment in patients recovered from Covid-19 with hospitalization history in comparison with the control group
Artesh University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 50 years（—）
- 性别
- All
入选标准
- •Patients with the age between 20- 50 years old
- •Memory impairment after recovery from Covid-19
- •Volunteer to participate in the study
排除标准
- •History of previous cognitive problems
- •History of CVA, head trauma or Cerebral hemorrhage
- •History of underlying physical illnesses affecting cognitive function such as cancer, thyroid disorders, physical disorders with features of cognitive impairment such as Alzheimer's or any type of degenerative neurological disorder such as Parkinson's
- •History of underlying mental illnesses such as major depression, anxiety disorders and psychotic disorders
- •Use of drugs that affect cognitive function such as antidepressants, benzodiazepines, and anticonvulsants such as phenobarbital
- •Drug, stimulant and alcohol using
研究者
相似试验
招募中
2 期
Clinical effectiveness of Donepezil Hydrochloride for radiation-induced memory disturbance in patients with brain tumorbrain tumorJPRN-UMIN000001945Department od Radiology, Kobe University Graduate School of Medicine30
已完成
不适用
Double Blind Study for Effects of Donepezil Hydrochloride on Parkinson's DiseaseParkinson's diseaseJPRN-UMIN000003080Clinical Research Center, Utano National Hospital, National Hospital Organization30
未知
4 期
Pharmacokinetics study of Donepezil HCl in subjects receiving haemodialysis.Renal FailureJPRN-jRCT1080221230Eisai Co., Ltd.12
招募中
3 期
evaluation of the effect dual combination of Donepezil and Betahistine in improving the symptoms of autism spectrum disorderAutism Spectrum Disorder.Autistic disorderF84.0IRCT20160905029714N2Tehran University of Medical Sciences30
进行中（未招募）
1 期
Evaluation of the efficacy of donepezil in the treatment of oxaliplatin-induced peripheral neuropathyEUCTR2021-005326-23-FRCHU de Clermont-Ferrand80